Literature DB >> 30468462

MicroRNA-31 inhibits osteosarcoma cell proliferation, migration and invasion by targeting PIK3C2A.

L-M Chao1, W Sun, H Chen, B-Y Liu, P-F Li, D-W Zhao.   

Abstract

OBJECTIVE: To elucidate the role of microRNA-31 (miR-31) in osteosarcoma and the molecular mechanism of miR-31 in the proliferation, migration, and invasion of osteosarcoma. PATIENTS AND METHODS: Real Time-quantitative Polymerase Chain Reaction (RT-qPCR) was used to examine the expression of microRNA-31 in human osteosarcoma tissues. Pearson's chi-squared test was used to analyze the correlation between microRNA-31 and clinicopathological features. Proliferation, migration, invasion, and PI3K3C2A protein in treated osteosarcoma cells were detected by Cell Counting Kit-8 (CCK-8) assay, transwell assay without Matrigel, transwell assay with Matrigel, and Western blot analysis, respectively.
RESULTS: qRT-PCR showed that miR-31 was down-regulated in osteosarcoma tissues compared with paired para-tumor bone tissues. The lower level of miR-31 was closely associated with high-grade osteosarcoma, metastasis, and poor overall survival. CCK-8 and transwell assay showed that miR-31 inhibited osteosarcoma cells proliferation, migration, and invasion. According to luciferase assay, miR-31 inhibits osteosarcoma cell proliferation, migration, and invasion through inhibiting PIK3C2A. Reversely, overexpression of PIK3C2A inhibited partial effect of miR-31 on proliferation, migration, and invasion in vitro.
CONCLUSIONS: MiR-31 inhibits osteosarcoma cell proliferation, migration, and invasion by targeting PICK3C2A. MiR-31 can thus be used as a therapeutic target in osteosarcoma treatment.

Entities:  

Year:  2018        PMID: 30468462     DOI: 10.26355/eurrev_201811_16254

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  N-VEGF, the Autoregulatory Arm of VEGF-A.

Authors:  Marina Katsman; Aviva Azriel; Guy Horev; Yitzhak Reizel; Ben-Zion Levi
Journal:  Cells       Date:  2022-04-11       Impact factor: 7.666

2.  LncRNA KCNQ1OT1 attenuates osteoarthritic chondrocyte dysfunction via the miR-218-5p/PIK3C2A axis.

Authors:  Yijun Liu; Ding Zhao; Xue Wang; Ying Dong; Fupeng Ding
Journal:  Cell Tissue Res       Date:  2021-03-30       Impact factor: 5.249

3.  miRNA-Dependent Regulation of AKT1 Phosphorylation.

Authors:  Mallory I Frederick; Tarana Siddika; Pengcheng Zhang; Nileeka Balasuriya; Matthew A Turk; Patrick O'Donoghue; Ilka U Heinemann
Journal:  Cells       Date:  2022-02-26       Impact factor: 6.600

4.  lncRNA FOXD2-AS1 Promotes the Retinoblastoma Cell Viability and Migration by Sponging miR-31.

Authors:  Yan Liang; Hong Wang; Ruiying Song; Xiuyan Yin
Journal:  Biomed Res Int       Date:  2022-06-23       Impact factor: 3.246

5.  Cross-Species Suppression of Hepatoma Cell Growth and Migration by a Schistosoma japonicum MicroRNA.

Authors:  Yu Lin; Shanli Zhu; Chao Hu; Jing Wang; Pengyue Jiang; Liufang Zhu; Zhengli Li; Sai Wang; Yuanbin Zhang; Xindong Xu; Weiqing Pan
Journal:  Mol Ther Nucleic Acids       Date:  2019-09-17       Impact factor: 8.886

6.  MicroRNA-410 serves as a candidate biomarker in hypoxic-ischemic encephalopathy newborns and provides neuroprotection in oxygen-glucose deprivation-injured PC12 and SH-SY5Y cells.

Authors:  Qinghong Meng; Peipei Yang; Yuanyuan Lu
Journal:  Brain Behav       Date:  2021-07-31       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.